MarginsXMarginsX
Home › Markets › Health Care › DWTX

Dogwood Therapeutics Inc. (DWTX)

DWTX trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$1.06
-8.62% on the day
Market cap
$40.5M
Nano cap
Revenue
Not reported in SEC XBRL data
Net income
Not reported in SEC XBRL data

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026.

Profile

FieldValue
TickerDWTX on Nasdaq
SectorHealth Care
IndustryBiotechnology: Pharmaceutical Preparations
CountryUnited States
IPO year2020
SEC CIK0001818844
SEC industry codePharmaceutical Preparations
Incorporated inDE

Financials

Not reported in SEC XBRL data.

Warning signs

Cash runway
3.6 months
$4.9M cash at September 30, 2026
Share count, 1 year
+1567.0%
2025-11-05 to 2026-11-03 · +4862.6% over 3 years
Going-concern doubt
Yes
10-Q filed November 6, 2026
Insider net buying, 12 months
$0
Through September 30, 2026
SignFindingSource
Going concernStates substantial doubt about continuing as a going concern.
"As a result, substantial doubt exists regarding our ability to continue as a going concern 12 months from the issuance of this Quarterly Report on Form 10-Q."
10-Q 2026-11-06
Cash and burn$4.9M cash; operating cash flow -$4.1M a quarter.Report 2026-09-30
Shares outstanding38,227,913 (2026-11-03); 2,293,162 a year earlier; 19,257,937 three years earlier. 3y figure adjusted for split (1-for-25 overall).Cover page 2026-11-03
Reverse splits, 3 years1; latest 1-for-25 on 2024-10-09Source 2024-10-09
Shelf and offerings, 12 months2 S-3/F-3 shelf filings; 2 424B5 takedowns, 2 at the marketLatest 2026-01-13
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorForvis Mazars, LLP, Atlanta, Georgia, United StatesPCAOB Form AP 2026-04-08
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-09-30
$100K-$4.9M-$4.6M$4.9MNo debt tagsNeeds four quarters10-Q 2026-11-06
Q2 2026
2026-06-30
Not filed-$11.5M-$3.6M$9.6MNo debt tagsNeeds four quarters10-Q 2026-11-06
Q1 2026
2026-03-31
Not filed-$5.0M-$4.6M$13.2MNo debt tagsNeeds four quarters10-Q 2026-11-06
Q4 2025
2025-12-31
Not filed-$3.8M-$3.6M$6.5MNo debt tagsNeeds four quarters10-K 2026-03-18
Q3 2025
2025-09-30
Not filed-$15.7M-$3.3M$10.1MNo debt tagsNeeds four quarters10-Q 2026-11-06
Q2 2025
2025-06-30
Not filed-$3.8M-$4.0M$13.4MNo debt tagsNeeds four quarters10-Q 2026-11-06
Q1 2025
2025-03-31
Not filed-$10.9M-$4.7M$17.5MNo debt tagsNeeds four quarters10-Q 2026-11-06
Q4 2024
2024-12-31
Not filed-$7.7M-$6.1M$14.8MNo debt tagsNeeds four quarters10-K 2026-03-18

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document
FORM S-3
S-32026-10-30
Latest annual report10-K2026-03-18
Latest quarterly / interim10-Q2026-11-06
Latest current report8-K2026-11-05
Latest proxyDEF 14A2026-04-27

Source: SEC EDGAR submissions feed, 332 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week-13.3%
1 month-14.6%
3 months-43.9%
Year to date-73.3%
1 year-79.7%
From 52-week high-83.7%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Biotechnology: Pharmaceutical Preparations

TickerCompanyPriceDayMarket cap
CNTBConnect Biopharma Holdings Limited$0.6430-5.05%$40.5M
ALDXAldeyra Therapeutics Inc.$0.6696+4.01%$40.4M
GANXGain Therapeutics Inc.$0.9402-9.60%$41.9M
ELTXElicio Therapeutics Inc.$1.48-1.33%$41.9M
IBOImpact BioMedical Inc.$4.91-4.47%$42.4M
HYPDHyperion DeFi Inc.$2.47-4.26%$38.3M
PLRXPliant Therapeutics Inc.$0.6932-0.55%$43.0M
BMEABiomea Fusion Inc.$0.5201-10.67%$37.8M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier